The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MC1463: Avatar-directed chemotherapy in platinum-resistant ovarian cancer.
 
Beverly Long
No Relationships to Disclose
 
Xiaonan Hou
Research Funding - Genentech (Inst); Tesaro (Inst)
 
Marc Becker
Employment - Boehringer Ingelheim
Patents, Royalties, Other Intellectual Property - Mayo Ventures
 
Jamison VanBlaricom
Stock and Other Ownership Interests - 3M
Research Funding - Genentech (Inst); Tesaro (Inst)
 
Evans Bradley
Research Funding - Genentech (Inst); Tesaro (Inst)
 
Andrea Elisabeth Wahner Hendrickson
No Relationships to Disclose
 
Ann L. Oberg
Consulting or Advisory Role - Procter & Gamble
 
Matthew John Maurer
No Relationships to Disclose
 
Ethan Heinzen
No Relationships to Disclose
 
John Kelly Camoriano
No Relationships to Disclose
 
Gerardo Colon-Otero
Research Funding - Novartis (Inst)
 
Jill K. Burton
No Relationships to Disclose
 
Kimberly Kalli
Patents, Royalties, Other Intellectual Property - Mayo Clinic (Inst)
 
Nathan R. Foster
No Relationships to Disclose
 
Paul Haluska
Employment - Merck
Stock and Other Ownership Interests - Merck
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Ansh Laboratories (Inst); Boehringer Ingelheim
Research Funding - Clovis Oncology (Inst); Genentech (Inst); Nektar (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - Mayo Ovarian Avatar Program- I have intellectual property related to this technology. Mayo Clinic and I received royalties on this technology
Travel, Accommodations, Expenses - Ansh Laboratories; Boehringer Ingelheim; Merck
 
Saravut John Weroha
Research Funding - Genentech; Tesaro
Patents, Royalties, Other Intellectual Property - Mayo Ventures